Skip to main content
OpenTrials

Clinical trial condition

Lung Adenocarcinoma

Explore clinical trials studying Lung Adenocarcinoma. Study availability and eligibility vary by location and protocol.

76 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Lung Adenocarcinoma trial results

Completed

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

NCT00126581

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +20 more
Locations
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States
  • Bay Area Breast Surgeons Inc Emeryville, California, United States
View all 96 locations
View Trial Details
Completed

A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma

NCT02093000

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations
  • Orszagos Koranyi TBC es Pulmonologiai Intezet Budapest, Hungary
  • Semmelweis Egyetem X; Pulmonologiai Klinika Budapest, Hungary
  • Uzsoki Utcai Korhaz Budapest, Hungary
  • Debreceni Egyetem, Klinikai Kozpont, Tudogyogyaszati Klinika Debrecen, Hungary
View all 16 locations
View Trial Details
Completed

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

NCT01294306

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details
Completed

Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib

NCT00716456

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details
Active, Not Recruiting

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00334815

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +15 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Saint Bernards Regional Medical Center Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
View all 61 locations
View Trial Details
Active, Not Recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

NCT05887492

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions